Wall Street is repricing how long Nike's turnaround will take

Nike’s latest selloff has produced a familiar headline: another analyst downgrade, another price-target cut and fresh doubts about the pace of the company’s recovery. Yet behind the market reaction lies a more nuanced question for the sporting goods industry: is Nike’s turnaround deteriorating, or is Wall Street simply recalibrating how long it will take?

The Dick’s shock that triggered the downgrade

The immediate trigger came this week when Truist analyst Joseph Civello downgraded Nike to hold from buy and lowered his price target to $42 from $47. The call followed Dick’s Sporting Goods’ sharp share-price decline after the retailer reduced its fiscal 2026 guidance and highlighted weaker footwear trends within Foot Locker, which it acquired earlier this year. Truist argued that the development introduces new uncertainty around Nike’s recovery, particularly given the brand’s significant exposure within the combined Dick’s and Foot Locker business.

The downgrade attracted attention partly because Civello had previously been among the more constructive voices on Nike’s prospects. His earlier optimism was based on encouraging signs in running, improving wholesale feedback and indications that inventory conditions were gradually normalizing. Following Dick’s results, however, he concluded that the scale of the required cleanup may be larger than previously anticipated.

Yet the broader debate around Nike began before this week’s market reaction.

A structural warning that predates the selloff

On Aug. 4, JPMorgan analyst Matthew Boss downgraded the company to underweight from neutral and reduced his price target to $40 from $47. His argument was notably different. Rather than focusing on short-term demand trends, Boss argued that the financial impact of Nike’s turnaround decisions could extend well into fiscal 2028. Key factors included ongoing distribution changes in Greater China and retailer restructuring efforts in North America, both of which he believes could pressure earnings longer than consensus forecasts currently anticipate. 

Neither Truist nor JPMorgan is arguing that Nike lacks scale, consumer awareness or global relevance. Instead, both firms are questioning the timeline and cost of the recovery.

Why the Hill turnaround runs on industry time, not market time

That timeline has become one of the most important debates surrounding CEO Elliott Hill, who returned to the company in late 2024 facing the task of rebuilding momentum across several fronts at once. Nike has been working to strengthen relationships with wholesale partners, refresh product assortments, reduce reliance on aging franchises and regain ground in performance categories where competitors have been gaining visibility.

Those initiatives may be strategically linked, but they rarely produce immediate financial benefits. From an industry perspective, this may be where Wall Street’s narrative diverges from the realities of sporting goods.

Product cycles in athletic footwear may span multiple seasons. Distribution resets can take years. Rebuilding credibility with specialty retailers requires consistency rather than a single successful launch. By those standards, judging the success or failure of a turnaround after only a handful of quarters can be premature.

The market-share backdrop

That does not mean Nike’s challenges are insignificant. Market-share trends show the company continues to face intense competition. According to Euromonitor data reported by Reuters, Nike’s share of the global sports-footwear market declined to 22.9 percent in 2025, marking a third consecutive annual decline, while adidas increased its share to 12.2 percent. The figures illustrate the pressure created by both established rivals and newer performance-focused brands.

Not every analyst is bailing

At the same time, analyst opinion is far from universally negative.

RBC Capital maintained a sector perform rating and a $45 price target following investor meetings with Hill in London, while Stifel reiterated its hold rating and $45 target. Both firms acknowledged that execution is taking longer than expected, but neither indicated the broader strategy had fundamentally changed. 

Around the same period, Bernstein SocGen reduced its target price while maintaining an outperform recommendation, viewing Nike’s China marketplace actions as part of a longer-term effort to support healthier full-price selling. Bank of America similarly described the recovery as uneven rather than broken when it adjusted its target in July.

The resulting picture is less dramatic than recent share-price moves might suggest. The disagreement is no longer centered on whether Nike needs to change course. Most observers agree that rebuilding product innovation, wholesale relationships and marketplace discipline is necessary. The debate is about how quickly those efforts can translate into growth and margin recovery.

Two industries, two clocks

In that sense, Nike’s recent stock performance may tell only part of the story.

Financial markets naturally focus on quarterly results, guidance revisions and earnings expectations. The sporting goods industry tends to evaluate brands differently, looking at product pipelines, retailer confidence, category standing and long-term consumer relevance. Those two timelines do not always move in sync.

For now, Wall Street appears to be reassessing how long Nike’s recovery may take. The industry’s verdict will likely require a longer view. What happens over the next several years may ultimately matter more than what happened during the last several weeks.